Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Prospects for Neuroprotective Therapies in Glaucoma: Drug Targets and Emerging Clinical Strategies
Drug design, development and therapy, 2026;20:612176
Prioritizing Antidiabetic Drugs for Inflammatory Bowel Disease Through Inverse Signal Detection: A FAERS Pharmacovigilance Study
Journal of clinical medicine, 2026;15(12)
Urological Complications of Morbid Obesity and the Role of Bariatric Surgery and Glucagon-Like Peptide-1 Receptor Agonists in Their Management: A Systematic Review
Cureus, 2026;18(6):e110952
Acute Nutritional Axonal Neuropathy in the Setting of Semaglutide-Associated Gastrointestinal Intolerance: A Case Report
Case reports in neurology, 2026;18(1):402-412
Real-world use of oral semaglutide in adults with type 2 diabetes
Danish medical journal, 2026;73(7)
Cardiometabolic Effects of Semaglutide in Individuals with Type 2 Diabetes in the United Arab Emirates: Real-World 12-Month Outcomes and Predictors of Response
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
GLP-1 Receptor Agonists in Aesthetic Surgery: A Narrative Review on Perioperative Safety, Sarcopenic Morphologies, and Adapted Body Contouring Strategies
Aesthetic plastic surgery, 2026
Temporal Trends and Clinical Characteristics of Incretin-Based Therapy Use in Women With Polycystic Ovary Syndrome: A Real-World Cohort Study From a Polish Private Healthcare Network
Diabetes, obesity & metabolism, 2026
Electrospun Nanofiber Oral Thin Film Platform for Sublingual Peptide Delivery: A Promising Alternative to Conventional Semaglutide Formulations
Diabetes, obesity & metabolism, 2026
The Effect of Semaglutide on Quality of Life in Adults With Overweight or Obesity: A Brief Systematic Review and Meta-Analysis
Diabetes, obesity & metabolism, 2026
Weight Changes With Lower Doses of Semaglutide in Clinical Practice: Findings From the Chinese HARMONY Cohort
Diabetes, obesity & metabolism, 2026
Semaglutide and Risk of Pancreatic Cancer: A Meta-Analysis of Randomised Trials
Diabetes, obesity & metabolism, 2026
SURMOUNT-REAL UK: A Pragmatic Randomized Clinical Trial to Assess the Effectiveness of Tirzepatide in Adults With Obesity
Obesity (Silver Spring, Md.), 2026
Tirzepatide monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO)
Med (New York, N.Y.), 2026;:101183
Hierarchical regulation and mechanism of “open-hollow-fibrous network” structures: Osteogenic-angiogenic coupling responses of poly(γ-benzyl-L-glutamate) microspheres
Biomaterials advances, 2026;188:215017
Sex, Not Age, Predicts Weight Loss Outcomes With Tirzepatide: A Retrospective Analysis
Obesity (Silver Spring, Md.), 2026
Effectiveness of tirzepatide in Japanese patients with type 2 diabetes but no obesity: A sub-analysis of Hokkaido-TZP study data
Journal of diabetes investigation, 2026
Current trends in semaglutide therapy and strategies to improve its bioavailability
Expert opinion on drug delivery, 2026
Therapeutic development in MASH: From accelerated approval to cirrhosis trial innovation
Med (New York, N.Y.);7(6):101172
Post hoc analysis of SURMOUNT-J: tirzepatide versus placebo and predicted 10-year cardiovascular disease risk in Japanese adults with obesity disease
Current medical research and opinion, 2026;:1-13